• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成和缺氧相关多态性对接受手术切除的肝细胞癌患者肿瘤复发的影响。

Impact of Angiogenesis- and Hypoxia-Associated Polymorphisms on Tumor Recurrence in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection.

作者信息

Miller Hannah, Czigany Zoltan, Lurje Isabella, Reichelt Sophie, Bednarsch Jan, Strnad Pavel, Trautwein Christian, Roderburg Christoph, Tacke Frank, Gaisa Nadine Therese, Knüchel-Clarke Ruth, Neumann Ulf Peter, Lurje Georg

机构信息

Charité-Universitätsmedizin Berlin, Department of Surgery, Campus Charité Mitte|Campus Virchow-Klinikum, 13353 Berlin, Germany.

Department of Surgery and Transplantation, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, 52074 Aachen, Germany.

出版信息

Cancers (Basel). 2020 Dec 18;12(12):3826. doi: 10.3390/cancers12123826.

DOI:10.3390/cancers12123826
PMID:33352897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7767259/
Abstract

Tumor angiogenesis plays a pivotal role in hepatocellular carcinoma (HCC) biology. Identifying molecular prognostic markers is critical to further improve treatment selection in these patients. The present study analyzed a subset of 10 germline polymorphisms involved in tumor angiogenesis pathways and their impact on prognosis in HCC patients undergoing partial hepatectomy in a curative intent. Formalin-fixed paraffin-embedded (FFPE) tissues were obtained from 127 HCC patients at a German primary care hospital. Genomic DNA was extracted, and genotyping was carried out using polymerase chain reaction (PCR)-restriction fragment length polymorphism-based protocols. Polymorphisms in interleukin-8 (IL-8) (rs4073; = 0.047, log-rank test) and vascular endothelial growth factor (VEGF C + 936T) (rs3025039; = 0.045, log-rank test) were significantly associated with disease-free survival (DFS). After adjusting for covariates in the multivariable model, IL-8 T-251A (rs4073) (adjusted = 0.010) and a combination of "high-expression" variants of rs4073 and rs3025039 (adjusted = 0.034) remained significantly associated with DFS. High-expression variants of IL-8 T-251A may serve as an independent molecular marker of prognosis in patients undergoing surgical resection for HCC. Assessment of the patients' individual genetic risks may help to identify patient subgroups at high risk for recurrence following curative-intent surgery.

摘要

肿瘤血管生成在肝细胞癌(HCC)生物学中起着关键作用。识别分子预后标志物对于进一步改善这些患者的治疗选择至关重要。本研究分析了10个参与肿瘤血管生成途径的种系多态性子集及其对接受根治性部分肝切除术的HCC患者预后的影响。从德国一家初级保健医院的127例HCC患者中获取福尔马林固定石蜡包埋(FFPE)组织。提取基因组DNA,并使用基于聚合酶链反应(PCR)-限制性片段长度多态性的方案进行基因分型。白细胞介素-8(IL-8)(rs4073;P = 0.047,对数秩检验)和血管内皮生长因子(VEGF C + 936T)(rs3025039;P = 0.045,对数秩检验)中的多态性与无病生存期(DFS)显著相关。在多变量模型中调整协变量后,IL-8 T-251A(rs4073)(调整后P = 0.010)以及rs4073和rs3025039的“高表达”变体组合(调整后P = 0.034)仍与DFS显著相关。IL-8 T-251A的高表达变体可能作为接受HCC手术切除患者预后的独立分子标志物。评估患者的个体遗传风险可能有助于识别根治性手术后复发风险高的患者亚组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf1/7767259/f5c3980ad907/cancers-12-03826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf1/7767259/f5c3980ad907/cancers-12-03826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf1/7767259/f5c3980ad907/cancers-12-03826-g001.jpg

相似文献

1
Impact of Angiogenesis- and Hypoxia-Associated Polymorphisms on Tumor Recurrence in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection.血管生成和缺氧相关多态性对接受手术切除的肝细胞癌患者肿瘤复发的影响。
Cancers (Basel). 2020 Dec 18;12(12):3826. doi: 10.3390/cancers12123826.
2
Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer.血管内皮生长因子(VEGF)和白细胞介素-8(IL-8)的多态性可预测III期结肠癌的肿瘤复发。
Ann Oncol. 2008 Oct;19(10):1734-41. doi: 10.1093/annonc/mdn368. Epub 2008 Jun 11.
3
Genetic Variant of CXCR1 (rs2234671) Associates with Clinical Outcome in Perihilar Cholangiocarcinoma.CXCR1基因变体(rs2234671)与肝门部胆管癌的临床结局相关。
Liver Cancer. 2022 Jan 25;11(2):162-173. doi: 10.1159/000521613. eCollection 2022 Apr.
4
Genetic polymorphisms in interleukin-1β (rs1143634) and interleukin-8 (rs4073) are associated with survival after resection of intrahepatic cholangiocarcinoma.白细胞介素-1β(rs1143634)和白细胞介素-8(rs4073)的遗传多态性与肝内胆管癌切除术后的生存相关。
Sci Rep. 2023 Jul 28;13(1):12283. doi: 10.1038/s41598-023-39487-7.
5
Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma.血管生成途径基因的遗传变异与局限性胃腺癌的临床结局相关。
Ann Oncol. 2010 Jan;21(1):78-86. doi: 10.1093/annonc/mdp280. Epub 2009 Jul 21.
6
Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.微血管密度和血管内皮生长因子表达在肝细胞癌及周围肝组织中的临床意义:血管内皮生长因子可能参与肝硬化肝脏的血管生成
Hepatology. 1998 Jun;27(6):1554-62. doi: 10.1002/hep.510270613.
7
Genetic variations in angiogenesis pathway genes predict tumor recurrence in localized adenocarcinoma of the esophagus.血管生成途径基因的遗传变异可预测食管局限性腺癌的肿瘤复发。
Ann Surg. 2010 May;251(5):857-64. doi: 10.1097/SLA.0b013e3181c97fcf.
8
Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation.INT 0144试验的药物遗传学分析:5-氟尿嘧啶与放疗联合治疗的直肠癌患者中基因多态性与生存及毒性的关联
Clin Cancer Res. 2015 Apr 1;21(7):1583-90. doi: 10.1158/1078-0432.CCR-14-0857. Epub 2015 Jan 14.
9
Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.根治性意向下接受部分肝切除术的肝细胞癌患者无病生存和总生存的预后因素。
Langenbecks Arch Surg. 2018 Nov;403(7):851-861. doi: 10.1007/s00423-018-1715-9. Epub 2018 Sep 28.
10
Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer.白细胞介素1β和白细胞介素1受体拮抗剂中的多态性与II期结肠癌的肿瘤复发相关。
Pharmacogenet Genomics. 2009 Feb;19(2):95-102. doi: 10.1097/FPC.0b013e32831a9ad1.

引用本文的文献

1
Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?联合治疗克服肝癌免疫检查点阻断耐药:强强联手?
Semin Liver Dis. 2024 May;44(2):159-179. doi: 10.1055/a-2334-8311. Epub 2024 May 28.
2
Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment.表皮调节素在癌症微环境中作为通过表皮生长因子受体信号传导的介质对脂多糖诱导的肝癌发生的作用。
Int J Mol Sci. 2024 Apr 17;25(8):4405. doi: 10.3390/ijms25084405.
3
The Significant Impacts of Interleukin-8 Genotypes on the Risk of Colorectal Cancer in Taiwan.

本文引用的文献

1
Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression.白细胞介素-8:癌症可塑性、血管生成和免疫抑制的交汇点的趋化因子。
Pharmacol Ther. 2021 Mar;219:107692. doi: 10.1016/j.pharmthera.2020.107692. Epub 2020 Sep 24.
2
Intraoperative Transfusion of Fresh Frozen Plasma Predicts Morbidity Following Partial Liver Resection for Hepatocellular Carcinoma.术中输注新鲜冷冻血浆可预测肝细胞癌部分肝切除术后的发病率。
J Gastrointest Surg. 2021 May;25(5):1212-1223. doi: 10.1007/s11605-020-04652-0. Epub 2020 Jun 3.
3
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
白细胞介素-8基因分型对台湾地区结直肠癌风险的显著影响。
Cancers (Basel). 2023 Oct 10;15(20):4921. doi: 10.3390/cancers15204921.
4
Osteopenia is associated with inferior survival in patients undergoing partial hepatectomy for hepatocellular carcinoma.骨量减少与接受肝癌部分肝切除术患者的生存预后不良相关。
Sci Rep. 2022 Oct 31;12(1):18316. doi: 10.1038/s41598-022-21652-z.
5
Tumor vessel normalization and immunotherapy in gastric cancer.胃癌中的肿瘤血管正常化与免疫治疗
Ther Adv Med Oncol. 2022 Jul 18;14:17588359221110176. doi: 10.1177/17588359221110176. eCollection 2022.
6
The Role of Sarcopenia and Myosteatosis in Short- and Long-Term Outcomes Following Curative-Intent Surgery for Hepatocellular Carcinoma in a European Cohort.肌肉减少症和肌脂肪变性在欧洲队列中肝细胞癌根治性手术后短期和长期预后中的作用
Cancers (Basel). 2022 Jan 30;14(3):720. doi: 10.3390/cancers14030720.
7
UDCA Inhibits Hypoxic Hepatocellular Carcinoma Cell-Induced Angiogenesis Through Suppressing HIF-1α/VEGF/IL-8 Intercellular Signaling.熊去氧胆酸通过抑制缺氧肝癌细胞诱导的血管生成,抑制HIF-1α/VEGF/IL-8细胞间信号传导。
Front Pharmacol. 2021 Dec 15;12:755394. doi: 10.3389/fphar.2021.755394. eCollection 2021.
8
Targeting tumor vascularization: promising strategies for vascular normalization.靶向肿瘤血管生成:血管正常化的有前途策略。
J Cancer Res Clin Oncol. 2021 Sep;147(9):2489-2505. doi: 10.1007/s00432-021-03701-8. Epub 2021 Jun 19.
9
Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma.接种疫苗作为调节肝癌免疫微环境的策略。
Front Immunol. 2021 May 7;12:650486. doi: 10.3389/fimmu.2021.650486. eCollection 2021.
阿替利珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌。
N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745.
4
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study.索拉非尼治疗晚期肝细胞癌患者的血管生成基因分型与临床结局:ALICE-2 研究。
Target Oncol. 2020 Feb;15(1):115-126. doi: 10.1007/s11523-020-00698-x.
5
Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes.缺氧:缺氧介导机制概述,重点介绍 HIF 基因的作用。
Int J Mol Sci. 2019 Dec 5;20(24):6140. doi: 10.3390/ijms20246140.
6
Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma.白细胞介素-8 通过 PI3K/Akt 通路促进肝癌细胞整合素 β3 的上调和细胞侵袭。
J Exp Clin Cancer Res. 2019 Nov 4;38(1):449. doi: 10.1186/s13046-019-1455-x.
7
High interleukin-8 and/or extracellular signal-regulated kinase 2 expression predicts poor prognosis in patients with hepatocellular carcinoma.高白细胞介素-8和/或细胞外信号调节激酶2表达预示肝细胞癌患者预后不良。
Oncol Lett. 2019 Nov;18(5):5215-5224. doi: 10.3892/ol.2019.10907. Epub 2019 Sep 23.
8
A systematic review and meta-analysis of evaluation of serum interleukin 8 levels in hepatocellular carcinoma.肝细胞癌血清白细胞介素8水平评估的系统评价与荟萃分析
Clin Exp Hepatol. 2019 May;5(2):123-128. doi: 10.5114/ceh.2019.84780. Epub 2019 Apr 30.
9
Genetic polymorphisms of vascular endothelial growth factor (VEGF) associated with gastric cancer recurrence after curative resection with adjuvant chemotherapy.血管内皮生长因子(VEGF)基因多态性与辅助化疗后根治性切除术后胃癌复发的关系。
BMC Cancer. 2019 May 22;19(1):483. doi: 10.1186/s12885-019-5702-5.
10
Treatment Strategies for Hepatocellular Carcinoma ⁻ a Multidisciplinary Approach.肝细胞癌的治疗策略 ⁇ 多学科方法。
Int J Mol Sci. 2019 Mar 22;20(6):1465. doi: 10.3390/ijms20061465.